Psychedelic Bulletin: DMT for Stroke; MindMed’s Drug Discovery Partnership; Psychedelics are in Vogue Post published:February 12, 2021 Post category:Psychedelic Bulletin
Psychedelic Bulletin: the Changing Psychedelic Research Landscape; Compass Publishes Therapist Training Programme; and more… Post published:February 4, 2021 Post category:Psychedelic Bulletin
Psychedelic Bulletin: Psychedelics ETF Launches; atai Collaborate with Mass General; McGill Publishes LSD Research Post published:January 29, 2021 Post category:Psychedelic Bulletin
Psychedelic Bulletin: Psychedelics Index Published; ETF Launching Jan 27; MindMed Commences Candyflipping Trial Post published:January 22, 2021 Post category:Psychedelic Bulletin
Psychedelic Bulletin: Psychedelics Companies Embrace Tech; MindMed to Study LSD Microdosing; UFC Eyes Psychedelics Post published:January 15, 2021 Post category:Psychedelic Bulletin
Psychedelic Bulletin: MindMed Raises $92.1m; Mount Sinai Establishes Psychedelics Centre; More Legal Exemptions for Psilocybin in Canada Post published:January 8, 2021 Post category:Psychedelic Bulletin
Psychedelic Bulletin: First Psychedelic ETF Set to Launch; Beckley Psytech Raises £14m; Reviewing the Psychedelic Renaissance in 2020 Post published:January 2, 2021 Post category:Psychedelic Bulletin
Psychedelic Bulletin: MindMed Raises $34.5m; Tryp Goes Public; What Health Canada’s Latest Amendment Means for Psychedelics Post published:December 18, 2020 Post category:Psychedelic Bulletin
Psychedelic Bulletin: Canadian Healthcare Professionals Allowed Psilocybin; UK Approves DMT Trial Post published:December 11, 2020 Post category:Psychedelic Bulletin
Psychedelic Bulletin: Numinus & MAPS Seek Approval for MDMA Trial in Canada; Psychedelic Companies Commission Research into Psilocybin, DMT, LSD Post published:December 4, 2020 Post category:Psychedelic Bulletin